BlackRock Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

BlackRock Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$223M	Buy	3,813,305 +64,172	+2%	+$3.51M	0.26%	80
2016 Q3	$202M	Buy	3,749,133 +30,944	+0.8%	+$1.99M	0.25%	84
2016 Q2	$273M	Sell	3,718,189 -862,724	-19%	-$61M	0.35%	55
2016 Q1	$293M	Sell	4,580,913 -691,205	-13%	-$43.6M	0.38%	48
2015 Q4	$363M	Sell	5,272,118 -165,987	-3%	-$11M	0.46%	41
2015 Q3	$322M	Sell	5,438,105 -1,729,396	-24%	-$110M	0.43%	46
2015 Q2	$477M	Buy	7,167,501 +73,252	+1%	+$4.83M	0.59%	28
2015 Q1	$458M	Buy	7,094,249 +148,394	+2%	+$9.29M	0.6%	29
2014 Q4	$410M	Sell	6,945,855 -42,996	-0.6%	-$2.42M	0.54%	31
2014 Q3	$358M	Sell	6,988,851 -196,359	-3%	-$9.81M	0.5%	38
2014 Q2	$349M	Buy	7,185,210 +112,278	+2%	+$5.53M	0.47%	39
2014 Q1	$367M	Buy	7,072,932 +47,659	+0.7%	+$2.54M	0.53%	32
2013 Q4	$373M	Sell	7,025,273 -126,138	-2%	-$6.43M	0.55%	31
2013 Q3	$331M	Buy	7,151,411 +116,657	+2%	+$5.12M	0.55%	29
2013 Q2	$314M	Buy	+7,034,754	New	+$305M	0.56%	30

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock Investment Management's BMY Position: Q4 2016 in Review

BlackRock Investment Management increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q4 2016, buying an estimated $3.51M and bringing the position to 3,813,305 shares worth $223M. The position accounts for 0.26% of the portfolio, ranked #80.

BlackRock Investment Management first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $477M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

BlackRock Investment Management held 3,813,305 shares of Bristol-Myers Squibb worth $223M as of Q4 2016.
BlackRock Investment Management bought 64,172 Bristol-Myers Squibb shares in Q4 2016, an estimated $3.51M.
Bristol-Myers Squibb made up 0.26% of BlackRock Investment Management's portfolio in Q4 2016, its #80 holding.
BlackRock Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Bristol-Myers Squibb position peaked at $477M in Q2 2015.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.